Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T D Gilmore

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Oncogene|December 22, 1999
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-RelT D Gilmore
Trends in Genetics : TIG|October 1, 1991
Malignant transformation by mutant Rel proteinsT D Gilmore
Oncogene|October 31, 2006
Introduction to NF-kappaB: players, pathways, perspectivesT D Gilmore
Oncogene|December 22, 1999
The Rel/NF-kappaB signal transduction pathway: introductionT D Gilmore
The Journal of Clinical Investigation|January 31, 1998
Clinically relevant findingsT D Gilmore
Cancer Surveys|January 1, 1992
Role of rel family genes in normal and malignant lymphoid cell growthT D Gilmore
Cell|September 7, 1990
NF-kappa B, KBF1, dorsal, and related mattersT D Gilmore
Oncogene|October 31, 2006
Inhibitors of NF-kappaB signaling: 785 and countingT D Gilmore, M Herscovitch
Oncogene|December 22, 1999
Control of apoptosis by Rel/NF-kappaB transcription factorsM Barkett, T D Gilmore
Oncogene|March 1, 1993
v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequenceG Mosialos, T D Gilmore
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|December 22, 1999
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-RelT D Gilmore
Trends in Genetics : TIG|October 1, 1991
Malignant transformation by mutant Rel proteinsT D Gilmore
Oncogene|October 31, 2006
Introduction to NF-kappaB: players, pathways, perspectivesT D Gilmore
Oncogene|December 22, 1999
The Rel/NF-kappaB signal transduction pathway: introductionT D Gilmore
The Journal of Clinical Investigation|January 31, 1998
Clinically relevant findingsT D Gilmore
Cancer Surveys|January 1, 1992
Role of rel family genes in normal and malignant lymphoid cell growthT D Gilmore
Cell|September 7, 1990
NF-kappa B, KBF1, dorsal, and related mattersT D Gilmore
Oncogene|October 31, 2006
Inhibitors of NF-kappaB signaling: 785 and countingT D Gilmore, M Herscovitch
Oncogene|December 22, 1999
Control of apoptosis by Rel/NF-kappaB transcription factorsM Barkett, T D Gilmore
Oncogene|March 1, 1993
v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequenceG Mosialos, T D Gilmore
Pageof 6